The emerging therapy of this peptide represents a major advance in the handling of diabetes mellitus type 2. Different to existing therapies, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide678209.win-blog.com/23334224/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment